Mark A. Ator
Impact in
- Inorganic Chemistry top 2%
- Metal-Catalyzed Oxygenation Mechanisms
- Oncology top 5%
- Metal complexes synthesis and properties
- Peptidase Inhibition and Analysis
- Cytokine Signaling Pathways and Interactions
Papers in
-
- Cancer therapeutics and mechanisms 9
- Receptor Mechanisms and Signaling 8
- Chemical Synthesis and Analysis 7
- Ubiquitin and proteasome pathways 6
- Oncology 33
- Peptidase Inhibition and Analysis 10
- Cytokine Signaling Pathways and Interactions 6
- Co-authors
- P.R. Ortiz de Montellano (3 shared papers)Roland E. Dolle (14 shared papers)Thelma S. Angeles (24 shared papers)Carla T. Helaszek (12 shared papers)J. Stubbe (4 shared papers)JoAnne Stubbe (2 shared papers)Bruce Ruggeri (18 shared papers)Robert L. Hudkins (16 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (23 papers)Journal of Medicinal Chemistry (18 papers)Biochemistry (8 papers)Molecular Cancer Therapeutics (5 papers)Journal of Biological Chemistry (5 papers)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Mark A. Ator
94 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 121
- Inorganic Chemistry 485
- Oncology 795
- Molecular Biology 1.9k
- Organic Chemistry 637
- Immunology 374
Countries citing papers authored by Mark A. Ator
This map shows the geographic impact of Mark A. Ator's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Ator with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Ator more than expected).
Fields of papers citing papers by Mark A. Ator
This network shows the impact of papers produced by Mark A. Ator. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Ator. The network helps show where Mark A. Ator may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. Ator, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1987 | 197 | |
| 2 | 1994 | 132 | |
| 3 | 2008 | 130 | |
| 4 | 1988 | 126 | |
| 5 | 2016 | 123 | |
| 6 | 1987 | 115 | |
| 7 | 2003 | 108 | |
| 8 | 1996 | 93 | |
| 9 | 2005 | 91 | |
| 10 | 1983 | 91 | |
| 11 | 2002 | 84 | |
| 12 | 2007 | 77 | |
| 13 | 2011 | 67 | |
| 14 | 2011 | 66 | |
| 15 | 2003 | 66 | |
| 16 | 2011 | 63 | |
| 17 | 2011 | 62 | |
| 18 | 2012 | 56 | |
| 19 | 2011 | 54 | |
| 20 | 1994 | 53 |
About Mark A. Ator
Mark A. Ator is a scholar working on Molecular Biology, Oncology, Immunology, Organic Chemistry and Cell Biology, having authored 94 papers that have together received 3.4k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (10 papers), Calpain Protease Function and Regulation (9 papers), Cancer therapeutics and mechanisms (9 papers), Receptor Mechanisms and Signaling (8 papers), Metal-Catalyzed Oxygenation Mechanisms (8 papers), Chemical Synthesis and Analysis (7 papers), Ubiquitin and proteasome pathways (6 papers) and Cytokine Signaling Pathways and Interactions (6 papers). The work is most often cited by research in Inorganic Chemistry (485 citations), Oncology (795 citations), Molecular Biology (1.9k citations), Organic Chemistry (637 citations) and Immunology (374 citations). Mark A. Ator has collaborated with scholars based in United States, France and Germany. Frequent co-authors include P.R. Ortiz de Montellano, Roland E. Dolle, Thelma S. Angeles, Carla T. Helaszek, J. Stubbe, JoAnne Stubbe, Bruce Ruggeri, Robert L. Hudkins, John P. Mallamo and Bruce D. Dorsey. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Biochemistry, Molecular Cancer Therapeutics and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.